T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Commercial Metals
CMC
$7.98B
| $1.8M | ﹤0.01% |
111,700
-5,500
| -5% | -$89.8K |
|
1602
SEI Investments
SEIC
$12.8B
| $1.79M | ﹤0.01% |
36,604
+142
| +0.4% | +$6.68K |
|
1603
National Fuel Gas
NFG
$7.75B
| $1.79M | ﹤0.01% |
30,328
-126
| -0.4% | -$7.96K |
|
1604
Herbalife
HLF
$1.28B
| $1.78M | ﹤0.01% |
64,800
| – | – |
|
1605
Starwood Property Trust
STWD
$6.05B
| $1.78M | ﹤0.01% |
82,600
-79,000
| -49% | -$1.87M |
|
1606
iShares MSCI EAFE ETF
EFA
$80.3B
| $1.78M | ﹤0.01% |
28,003
+1,242
| +5% | +$82.7K |
|
1607
Service Corp International
SCI
$11.3B
| $1.76M | ﹤0.01% |
59,831
-2,500
| -4% | -$70.9K |
|
1608
Albemarle
ALB
$15.4B
| $1.75M | ﹤0.01% |
31,700
| – | – |
|
|
DFRG
1609
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $1.73M | ﹤0.01% |
92,800
+20,900
| +29% | +$410K |
|
1610
Trinity Industries
TRN
$2.34B
| $1.71M | ﹤0.01% |
89,809
+319
| +0.4% | +$7.15K |
|
1611
Aecom
ACM
$8.19B
| $1.71M | ﹤0.01% |
51,531
| – | – |
|
|
GNRT
1612
DELISTED
Gener8 Maritime, Inc.
GNRT
| $1.7M | ﹤0.01% |
+125,000
| New | +$1.68M |
|
1613
Hallador Energy
HNRG
$730M
| $1.69M | ﹤0.01% |
202,678
+99,087
| +96% | +$1M |
|
|
NRF
1614
DELISTED
NorthStar Realty Finance Corp.
NRF
| $1.69M | ﹤0.01% |
53,029
+7,690
| +17% | +$277K |
|
1615
Wolfspeed
WOLF
$1.64B
| $1.65M | ﹤0.01% |
63,362
+580
| +0.9% | +$18.2K |
|
|
BZC
1616
DELISTED
BREEZE-EASTERN CORPORATION COM
BZC
| $1.64M | ﹤0.01% |
142,658
-88,210
| -38% | -$955K |
|
1617
CoreCivic
CXW
$3.13B
| $1.64M | ﹤0.01% |
49,504
+3,100
| +7% | +$113K |
|
1618
SLM Corp
SLM
$5.22B
| $1.63M | ﹤0.01% |
164,729
| – | – |
|
1619
Spire
SR
$4.9B
| $1.63M | ﹤0.01% |
31,210
+2,500
| +9% | +$130K |
|
1620
Theravance Biopharma
TBPH
$878M
| $1.62M | ﹤0.01% |
124,685
+700
| +0.6% | +$10.9K |
|
1621
CNO Financial Group
CNO
$5.07B
| $1.62M | ﹤0.01% |
88,154
+10,416
| +13% | +$189K |
|
|
HOUS
1622
DELISTED
Anywhere Real Estate
HOUS
| $1.61M | ﹤0.01% |
34,504
+450
| +1% | +$20.9K |
|
|
ODP
1623
DELISTED
ODP
ODP
| $1.59M | ﹤0.01% |
18,371
+910
| +5% | +$83.7K |
|
|
WOOF
1624
DELISTED
VCA Inc.
WOOF
| $1.59M | ﹤0.01% |
29,200
| – | – |
|
|
UFS
1625
DELISTED
DOMTAR CORPORATION (New)
UFS
| $1.58M | ﹤0.01% |
38,082
+3,300
| +9% | +$144K |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.